Search

Abstract An array of gold interdigitated microelectrodes (Au-IDA) has been modified by casting herringbone carbon nanotubes (hCNTs) producing a new electrochemical sensor suitable for the simultaneous determination of ascorbic acid (AA) and uric acid (UA) in PBS (0.25 M, pH 7.0). The sensor showed good electrocatalytic properties for both analytes with low working potentials, linear ranges between 0 and 600 μM for AA, and between 0 and 420 μM for UA. The empirical limits of detection (LODs) and the limits of quantification (LOQs) for both analytes were 15 μM and 50 μM, respectively. Moreover, UA does not interfere in the measurement of AA and vice versa. Furthermore, the presence of common analytes in physiological fluids as glucose, dopamine and epinephrine do not interfere in the quantification neither AA nor UA. [ABSTRACT FROM AUTHOR]

An electrochemical sensor based on graphene oxide decorated with gold nanoparticles has been prepared for the simultaneous quantification of uric acid (UA) and ascorbic acid (AA) in urine samples. The gold interdigitated microelectrodes array (Au-IDA) has been modified using graphene oxide doped with gold nanoparticles (AuNPs-GO/Au-IDA), which was characterized by TEM, FE-SEM, XPS and cyclic voltammetry. Excellent results were obtained for the separate quantification of UA and AA by chronoamperometry. The electrochemical sensor exhibits limits of detection (LODs) of 1.4 μM and 0.62 μM for AA and UA, respectively, limits of quantification (LOQs) of 4.6 μM (AA) and 2.0 μM (UA), and the working ranges obtained were between 4.6 μM and 193 μM for AA and between 2 μM and 1.05 mM for UA. The repeatability was studied at 20 μM providing coefficients of variation of 16% for AA and 13% for UA. Moreover, UA does not interfere in the measurement of AA and viceversa (provided that the concentration of UA is equal to or higher than 450 μM in the latter case). For lower concentrations of UA, an easy and fast strategy to quantify both analytes is presented. The good electrocatalytic activity achieved with this material makes it useful for the quantification of AA and UA in biological fluids. Other analytes like glucose, dopamine and epinephrine have been investigated. The results allow us to conclude that they do not interfere in the quantification of AA and UA in PBS (0.25 M, pH 7.0). Human urine samples have been analyzed using the method proposed, contaning AA and UA concentration levels of (0.588 ± 0.002) mM and (1.43 ± 0.02) mM, respectively, which are in the concentration range of these analytes in urine samples for healthy people. [ABSTRACT FROM AUTHOR]

A new portable electrochemical sensor based on 4-aminobenzoic acid-modified herringbone carbon nanotubes (hCNTs-4ABA/Au-IDA) has been developed for the simultaneous determination of ascorbic acid (AA) and uric acid (UA) in physiological fluids. AA and UA were quantified by chronoamperometry at 0.1 and 0.32 V, respectively, in phosphate buffer solution (PBS 0.25 M, pH 7.0). Significant results were obtained for the separate quantification of AA and UA, with a limit of detection (LOD) of 0.65 μM for both analytes, and sensitivities of (9.0 ± 0.4) A g −1 mM −1 and (8.8 ± 0.3) A g −1 mM −1 for AA and UA, respectively. Repeatability was studied at 50 μM for AA and UA, providing relative standard deviations (RSD) lower than 9%. Additions of glucose, dopamine and epinephrine did not interfere with the AA and UA determination. Furthermore, UA did not interfere with AA determination at 0.1 V, although AA additions increased the current recorded at 0.32 V. The method has been successfully applied to human urine, perspiration and serum samples, without significant matrix effects, which allows for the use of an external calibration and the analysis of all the matrices investigated. [ABSTRACT FROM AUTHOR]

Gold interdigitated microelectrodes (Au-IDA) modified with either graphene flakes exfoliated using flavin mononucleotide (FMN) (Gr-FMN) or graphene flakes and platinum nanoparticles (Pt-Gr-FMN) have been studied in the oxidation of uric acid (UA). An electrochemical method for the detection and quantification of UA in phosphate buffer solution at physiological pH (PBS, 0.25 M, pH 7) in the absence and presence of ascorbic acid (AA) has been studied by cyclic voltammetry. The quantification of UA was investigated by cyclic voltammetry, presenting an oxidation peak at 0.99 V with both modified electrodes. Linearity range of 60–578 μM and 60–345 μM has been found for Gr-FMN/Au-IDA and Pt-Gr-FMN/Au-IDA electrodes, respectively. Limits of detection of 18 μM were obtained for both electrodes, and the repeatability was studied at 177 μM providing 4% and 8% for Gr-FMN/Au-IDA and Pt-Gr-FMN/Au-IDA, respectively. AA interference has been studied by cyclic voltammetry, showing two clearly separated oxidation peaks, at 0.99 V for UA oxidation and at 0.74 V for Gr-FMN/Au-IDA and 0.70 V for Pt-Gr-FMN/Au-IDA for AA oxidation. Linearity range has been studied in presence of 250 μM AA obtaining a working range of 60–578 μM for Gr-FMN/Au-IDA electrode and of 60–288 μM with Pt-Gr-FMN/Au-IDA electrode. Limits of detection remain at 18 μM for both electrodes and the repeatability was studied at 177 μM providing 8% and 14% for Gr-FMN/Au-IDA and Pt-Gr-FMN/Au-IDA electrodes respectively. [ABSTRACT FROM AUTHOR]

Here we present two types of all-printable, highly stretchable, and inexpensive devices based on platinum (Pt)-decorated graphite for glucose determination in physiological fluids. Said devices are: a non-enzymatic sensor and an enzymatic biosensor, the latter showing promising results. Glucose has been quantified by measuring hydrogen peroxide (H 2 O 2 ) reduction by chronoamperometry at −0.35 V (vs pseudo-Ag/AgCl) using glucose oxidase immobilized on Pt-decorated graphite. The sensor performs well for the quantification of glucose in phosphate buffer solution (0.25 M PBS, pH 7.0), with a linear range between 0 mM and 0.9 mM, high sensitivity and selectivity, and a low limit of detection (LOD). Thus, it provides an alternative non-invasive and on-body quantification of glucose levels in human perspiration. This biosensor has been successfully applied on real human perspiration samples and results also show a significant correlation between glucose concentration in perspiration and glucose concentration in blood measured by a commercial glucose meter. [ABSTRACT FROM AUTHOR]